BioStem Technologies, Inc. (BSEM)
3.92
+0.38
(+10.73%)
USD |
NASDAQ |
Aug 24, 16:00
3.86
-0.06
(-1.53%)
After-Hours: 20:00
BioStem Technologies Debt to Equity Ratio : 0.0443 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0443 |
| March 31, 2026 | 0.1029 |
| December 31, 2025 | 0.0851 |
| September 30, 2025 | 0.0677 |
| June 30, 2025 | 0.0746 |
| March 31, 2025 | 0.0906 |
| December 31, 2024 | 0.1098 |
| September 30, 2024 | 0.1962 |
| June 30, 2024 | 0.2974 |
| March 31, 2024 | 0.6564 |
| December 31, 2023 | -3.551 |
| September 30, 2023 | -1.728 |
| June 30, 2023 | -1.107 |
| March 31, 2023 | -1.107 |
| December 31, 2022 | -1.278 |
| September 30, 2022 | -1.563 |
| June 30, 2022 | -1.706 |
| March 31, 2022 | -1.599 |
| December 31, 2021 | -0.8107 |
| September 30, 2021 | -0.9469 |
| June 30, 2021 | -0.9349 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.9722 |
| December 31, 2020 | -1.011 |
| September 30, 2020 | -1.030 |
| June 30, 2020 | -1.148 |
| March 31, 2020 | -1.166 |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -3.229 |
| September 30, 2018 | 4.604 |
| June 30, 2018 | 7.217 |
| March 31, 2018 | 0.849 |
| December 31, 2017 | 1.133 |
| September 30, 2017 | 0.7069 |
| June 30, 2017 | 0.2847 |
| March 31, 2017 | 0.2593 |
| December 31, 2016 | 1.815 |
| September 30, 2016 | 1.088 |
| June 30, 2016 | 0.429 |
| March 31, 2016 | 0.4251 |
| June 30, 2014 | 0.4676 |
| March 31, 2014 | 0.6734 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.2335 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 48.82M |
| Total Liabilities (Quarterly) | 21.20M |
| Shareholders Equity (Quarterly) | 27.61M |
| Current Ratio | 0.9801 |
| Net Debt Paydown Yield | 1.05% |